Sagespring Wealth Partners’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$805K Buy
2,082
+964
+86% +$358K 0.01% 396
2026
Q1
$327K Sell
1,118
-223
-17% -$73.3K 0.01% 627
2025
Q4
$470K Buy
1,341
+168
+14% +$56.8K 0.01% 493
2025
Q3
$379K Sell
1,173
-407
-26% -$127K 0.01% 531
2025
Q2
$615K Buy
1,580
+241
+18% +$96.9K 0.01% 380
2025
Q1
$582K Buy
1,339
+640
+92% +$257K 0.01% 353
2024
Q4
$258K Buy
+699
New +$293K 0.01% 518

Other funds holding ELV

Sagespring Wealth Partners's ELV Position: Q2 2026 in Review

Sagespring Wealth Partners increased its Elevance Health (ELV) stake by 86% in Q2 2026, buying an estimated $358K and bringing the position to 2,082 shares worth $805K. The position accounts for 0.01% of the portfolio, ranked #396.

Sagespring Wealth Partners first reported a position in ELV in Q4 2024 and has held it in 7 quarters since. 1,609 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Sagespring Wealth Partners held 2,082 shares of Elevance Health worth $805K as of Q2 2026.
  • Sagespring Wealth Partners bought 964 Elevance Health shares in Q2 2026, an estimated $358K.
  • Elevance Health made up 0.01% of Sagespring Wealth Partners's portfolio in Q2 2026, its #396 holding.
  • Sagespring Wealth Partners first reported a position in Elevance Health in Q4 2024 and has held it in 7 quarters since.
  • 1,609 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Sagespring Wealth Partners's 13F filing for Q2 2026, filed 3 Aug 2026.